Patent | Date |
---|
Substituted Dihydropyrazolones For Treating Cardiovascular And Hematological Diseases App 20160229858 - THEDE; Kai ;   et al. | 2016-08-11 |
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases Grant 9,168,249 - Thede , et al. October 27, 2 | 2015-10-27 |
4-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases Grant 9,085,572 - Flamme , et al. July 21, 2 | 2015-07-21 |
Substituted Dihydropyrazolones For Treating Cardiovascular And Hematological Diseases App 20150148381 - THEDE; Kai ;   et al. | 2015-05-28 |
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases Grant 8,987,261 - Thede , et al. March 24, 2 | 2015-03-24 |
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases Grant 8,653,111 - Thede , et al. February 18, 2 | 2014-02-18 |
Substituted Dihydropyrazolones For Treating Cardiovascular And Hematological Diseases App 20140031329 - THEDE; Kai ;   et al. | 2014-01-30 |
Substituted dipyridyl-dihydropyrazolones and use thereof Grant 8,609,698 - Thede , et al. December 17, 2 | 2013-12-17 |
Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors Grant 8,524,699 - Thede , et al. September 3, 2 | 2013-09-03 |
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases Grant 8,389,520 - Thede , et al. March 5, 2 | 2013-03-05 |
Substituted Imidazopyrimidines And Triazolopyrimidines App 20120322772 - FLAMME; Ingo ;   et al. | 2012-12-20 |
Substituted Dihydropyrazolones And Use Thereof As Hif-prolyl-4 -hydroxylase Inhibitors App 20120264704 - Thede; Kai ;   et al. | 2012-10-18 |
Dipyridyl-dihydropyrazolones and their use Grant 8,252,817 - Flamme , et al. August 28, 2 | 2012-08-28 |
Raf Kinase Inhibitors App 20120178780 - WOOD; Jill E. ;   et al. | 2012-07-12 |
Substituted Dihydropyrazolones For Treating Cardiovascular And Hematological Diseases App 20120121727 - THEDE; Kai ;   et al. | 2012-05-17 |
Substituted Dihydropyrazolones For Treating Cardiovascular And Hematological Diseases App 20100305085 - Thede; Kai ;   et al. | 2010-12-02 |
Substituted Dipyridyl-dihydropyrazolones And Use Thereof App 20100093803 - Thede; Kai ;   et al. | 2010-04-15 |
Raf Kinase Inhibitors App 20100063088 - WOOD; Jill E. ;   et al. | 2010-03-11 |
Dipyridyl-dihydropyrazolones and their use App 20100035906 - Flamme; Ingo ;   et al. | 2010-02-11 |
Use of substituted 2,5-diamidoindoles for the treatment of urological diseases App 20060183753 - Erguden; Jens ;   et al. | 2006-08-17 |
Substituted 2,5-diamidoindoles as ECE inhibitors for the treatment of cardiovascular diseases Grant 7,045,544 - Erguden , et al. May 16, 2 | 2006-05-16 |
Raf kinase inhibitors App 20050256174 - Wood, Jill E. ;   et al. | 2005-11-17 |
Substituted 2 5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases App 20050038101 - Erguden, Jens-Kerim ;   et al. | 2005-02-17 |
Raf kinase inhibitors App 20010006975 - Wood, Jill E. ;   et al. | 2001-07-05 |
Inhibition of raf kinase activity using aryl ureas Grant 6,187,799 - Wood , et al. February 13, 2 | 2001-02-13 |
Heteroatom-containing cyclopentanopyridyl-oxazolidinones Grant 5,869,659 - Stolle , et al. February 9, 1 | 1999-02-09 |
Benzofuranyl -and benzothienyloxazolidinones Grant 5,684,023 - Riedl , et al. November 4, 1 | 1997-11-04 |
6-membered nitrogen-containing heteroaryl-oxazolidinones Grant 5,627,181 - Riedl , et al. May 6, 1 | 1997-05-06 |
Use of substituted chromans, some of which are known, as medicaments, new active compounds and processes for their preparation Grant 5,492,918 - Wild , et al. February 20, 1 | 1996-02-20 |